Back to top
more

ModivCare (MODV)

(Delayed Data from NSDQ)

$2.33 USD

2.33
220,915

-0.07 (-2.92%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $2.36 +0.03 (1.29%) 7:56 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (98 out of 246)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Zacks.com featured highlights include: TimkenSteel, Genco Shipping & Trading, PDC Energy, Capital Product Partners and ModivCare

by Zacks Equity Research

Zacks.com featured highlights include: TimkenSteel, Genco Shipping & Trading, PDC Energy, Capital Product Partners and ModivCare

Anirudha Bhagat headshot

5 Top-Ranked Stocks With Impressive Net Profit Margins

by Anirudha Bhagat

Let's take a look at the five buy-ranked stocks - TMST, GNK, PDCE, CPLP and MODV - with solid net profit margins for an enriching portfolio.

Urmimala Biswas headshot

5 Finest Value Stocks Based on PEG Ratio

by Urmimala Biswas

Here are five value stocks, CAR, MODV, LNVGY, PAG and ATCO, which qualify the screening criteria.

Zacks Equity Research

MODV or AMEH: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

MODV vs. AMEH: Which Stock Is the Better Value Option?

Zacks Equity Research

Down 15.4% in 4 Weeks, Here's Why ModivCare (MODV) Looks Ripe for a Turnaround

by Zacks Equity Research

The heavy selling pressure might have exhausted for ModivCare (MODV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Zacks Equity Research

ModivCare (MODV) Sees Hammer Chart Pattern: Time to Buy?

by Zacks Equity Research

ModivCare (MODV) has been struggling lately, but the selling pressure may be coming to an end soon.

Zacks Equity Research

ModivCare (MODV) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

by Zacks Equity Research

ModivCare (MODV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Zacks Equity Research

Zacks.com featured highlights include: ModivCare, Meridian Corp, Genco Shipping, Capital Product Partners and Costamare

by Zacks Equity Research

Zacks.com featured highlights include: ModivCare, Meridian Corp, Genco Shipping, Capital Product Partners and Costamare

Anirudha Bhagat headshot

5 Top-Rated Stocks With Solid Net Profit Margins

by Anirudha Bhagat

Here are five top-ranked stocks with solid net profit margins that can contribute toward making a solid portfolio.

Zacks Equity Research

MODV vs. AMEH: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

MODV vs. AMEH: Which Stock Is the Better Value Option?

Zacks Equity Research

ModivCare (MODV) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

ModivCare (MODV) delivered earnings and revenue surprises of 35.83% and 1.34%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate ModivCare (MODV) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

ModivCare (MODV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Here's Why You Should Invest in Charles River (CRL) Now

by Zacks Equity Research

Investors are optimistic about Charles River (CRL) on solid second-quarter performance and bullish 2021 guidance.

Zacks Equity Research

MODV vs. GDRX: Which Stock Is the Better Value Option?

by Zacks Equity Research

MODV vs. GDRX: Which Stock Is the Better Value Option?

Zacks Equity Research

Avantor, Inc. (AVTR) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Acadia Healthcare (ACHC) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Acadia Healthcare (ACHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Zacks Industry Outlook Highlights: HealthEquity, Progyny, Surgery Partners, ModivCare and Agiliti

by Zacks Equity Research

Zacks Industry Outlook Highlights: HealthEquity, Progyny, Surgery Partners, ModivCare and Agiliti

Urmimala Biswas headshot

5 Medical Services Stocks Countering Industry Headwinds

by Urmimala Biswas

The Zacks Medical - Services industry is growing on digital healthcare adoption. HQY, PGNY, SGRY, MODV, and AGTI are set to gain the most. However, falling healthcare spending may disrupt the trend.

Zacks Equity Research

MODV vs. GDRX: Which Stock Is the Better Value Option?

by Zacks Equity Research

MODV vs. GDRX: Which Stock Is the Better Value Option?

Zacks Equity Research

Here's What Could Help ModivCare (MODV) Maintain Its Recent Price Strength

by Zacks Equity Research

ModivCare (MODV) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Zacks Equity Research

MODV or CRL: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

MODV vs. CRL: Which Stock Is the Better Value Option?

Zacks Equity Research

ModivCare (MODV) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

ModivCare (MODV) delivered earnings and revenue surprises of 43.92% and 1.43%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: ModivCare (MODV) Q2 Earnings Expected to Decline

by Zacks Equity Research

ModivCare (MODV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

ModivCare (MODV) Tops Q1 Earnings Estimates

by Zacks Equity Research

ModivCare (MODV) delivered earnings and revenue surprises of 12.94% and -0.05%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Sapna Bagaria headshot

Healthcare Stock Q1 Earnings Due on May 7: ELAN, MD, MODV

by Sapna Bagaria

Varied companies across the vast healthcare space might have been affected differently by the COVID crisis during the first quarter.